News & Events about Bridgebio Pharma Inc.
Thinking about buying stock in Western Alliance Bancorp, Genprex, Windtree Therapeutics, BridgeBio Pharma, or PacWest Bancorp? Thinking about buying stock in Western Alliance Bancorp, Genprex, Windtree Therapeutics, BridgeBio Pharma, or PacWest Bancorp? PR Newswire NEW YORK, April 19, 2023 NEW...
PALO ALTO, Calif., April 07, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that on March 7, 2023, the compensation committee of BridgeBios board of ...
Globe Newswire
2 months ago
- BridgeBio will also share 15-month Phase 2 data and review the Phase 3 clinical trial design of BBP-418, a potential therapeutic for patients with LGMD2I, with initiation of its Phase 3 study expected in mid-2023 - Preliminary findings and study results will be presented in an oral presentation ...
Globe Newswire
2 months ago
PALO ALTO, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced the pricing on March 7, 2023 of an underwritten public offering of 8,823,530 shares of its ...
Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? Thinking about buying stock in BridgeBio Pharma, Kala Pharmaceuticals, Azul, Unicycive Therapeutics, or Ciena Corp? PR Newswire NEW YORK, March 6, 2023 NEW YORK, March 6, 2023...